Syndax Pharmaceuticals

This study tested a drug called revumenib in 42 adults with colorectal cancer or other solid tumors that had spread or come back after at least one prior treatment. The main goals were to check safety, find the right dose, and see if the drug could shrink tumors or slow their gro…

This study tested a drug called axatilimab in 41 people with chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant where donor cells attack the body. Participants had already tried at least 2 other treatments. The goal was to find a safe dose and …